Federica Sarno
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
DNA methylation as a driver of lung fibroblast senescence in COPD.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: July 08, 2026
Lysine demethylase (KDM) inhibitors for the treatment of cancer: a patent review (2015-present).
Journal: Expert opinion on therapeutic patents
Published: December 10, 2025
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.
Journal: Journal of hematology & oncology
Published: October 27, 2025
The Promise of Epigenetic Editing for Treating Brain Disorders.
Journal: Sub-cellular biochemistry
Published: January 17, 2025
Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 16, 2024
Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 16, 2024
Cancer Therapy Resistance: Choosing Kinase Inhibitors.
Journal: Pharmaceutics
Published: February 20, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447.
Journal: Cancers
Published: January 29, 2024
In-silico guided chemical exploration of KDM4A fragments hits.
Journal: Clinical epigenetics
Published: August 07, 2023
Functional Validation of the Putative Oncogenic Activity of PLAU.
Journal: Biomedicines
Published: November 24, 2022
Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?
Journal: Advances in experimental medicine and biology
Published: November 09, 2022
Last Updated: 09/26/2026